Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1973 1
1974 2
1975 1
1979 1
1981 1
1983 2
1984 3
1985 1
1988 2
2015 3
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
The barber-surgeons.
Zielonka JS. Zielonka JS. J Hist Med Allied Sci. 1974 Jul;29(3):330-1. J Hist Med Allied Sci. 1974. PMID: 4605217 No abstract available.
BIOSIMILARS AND NEW INSULIN VERSIONS.
Peters AL, Pollom RD, Zielonka JS, Carey MA, Edelman SV. Peters AL, et al. Among authors: zielonka js. Endocr Pract. 2015 Dec;21(12):1387-94. doi: 10.4158/EP14595.RA. Epub 2015 Sep 4. Endocr Pract. 2015. PMID: 26340139 Review.
Inoculation: pro and con.
Zielonka JS. Zielonka JS. J Hist Med Allied Sci. 1972 Oct;27(4):447. doi: 10.1093/jhmas/xxvii.4.447. J Hist Med Allied Sci. 1972. PMID: 4563355 No abstract available.
Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus.
Ilag LL, Deeg MA, Costigan T, Hollander P, Blevins TC, Edelman SV, Konrad RJ, Ortmann RA, Pollom RK, Huster WJ, Zielonka JS, Prince MJ. Ilag LL, et al. Among authors: zielonka js. Diabetes Obes Metab. 2016 Feb;18(2):159-68. doi: 10.1111/dom.12584. Epub 2016 Jan 8. Diabetes Obes Metab. 2016. PMID: 26434665 Free PMC article. Clinical Trial.
Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine (Lantus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 study.
Blevins TC, Dahl D, Rosenstock J, Ilag LL, Huster WJ, Zielonka JS, Pollom RK, Prince MJ. Blevins TC, et al. Among authors: zielonka js. Diabetes Obes Metab. 2015 Aug;17(8):726-33. doi: 10.1111/dom.12496. Epub 2015 Jun 23. Diabetes Obes Metab. 2015. PMID: 25974640 Clinical Trial.
Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin-naïve or previously treated with insulin glargine: a randomized, double-blind controlled trial (the ELEMENT 2 study).
Rosenstock J, Hollander P, Bhargava A, Ilag LL, Pollom RK, Zielonka JS, Huster WJ, Prince MJ. Rosenstock J, et al. Among authors: zielonka js. Diabetes Obes Metab. 2015 Aug;17(8):734-41. doi: 10.1111/dom.12482. Epub 2015 May 31. Diabetes Obes Metab. 2015. PMID: 25931141 Clinical Trial.
20 results